Latest News about Exclusives
Recent news which mentions Exclusives
EXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused Entity
April 17, 2025
From Benzinga
EXCLUSIVE: La Rosa FY24 Revenue Jumps 119%, CEO Reiterates FY25 Topline Goal Of $100 Million
April 16, 2025
From Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal Study
April 16, 2025
From Benzinga
EXCLUSIVE: When Volatility (VIX) Peaks, Will That Be The Bottom? Watch These Signals, Says Direxion Expert
April 15, 2025
From Benzinga
From Benzinga
From Benzinga
Exclusive: Argent's New ETFs Are Not Chasing AI Or Meme Stocks, Here's What They're Buying Instead
April 15, 2025
From Benzinga
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs
April 15, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Tariff Uncertainty Turns Traders Cautious — But Oil, Silver Might Be The Escape Hatch, Says Market Analyst
April 14, 2025
From Benzinga
EXCLUSIVE: Janover Acquires $4.6 Million Of Solana (SOL), Begins Digital Asset Treasury Strategy
April 10, 2025
From Benzinga
Exclusive: From Corn To Crypto - Teucrium CEO Talks Strategy, Risk And Launch Of XXRP
April 09, 2025
Tickers
XXRP
From Benzinga
EXCLUSIVE: Capstone Eyes $100 Million Goal With Southeast Expansion, Targets 1,500 Acquisition Opportunities
April 09, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.